M Rusnati

Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies.

M. Rusnati, M. Presta, M Rusnati, 2007, Current pharmaceutical design.

Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.

M. Rusnati, M. Presta, M Rusnati, 1994, The Biochemical journal.

alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells.

P. Dell’Era, M. Rusnati, M. Presta, 1997, Molecular biology of the cell.

Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans

M. Rusnati, M. Presta, M Rusnati, 1996, International journal of clinical & laboratory research.

Heparin derivatives as angiogenesis inhibitors.

M. Rusnati, M. Presta, R. Ronca, 2003, Current pharmaceutical design.

Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.

R. Esnouf, E. De Clercq, J. Neyts, 1999, Molecular pharmacology.

Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.

A Vacca, D. Ribatti, L. Morbidelli, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form

M. Rusnati, M. Presta, J. Maier, 1989, Journal of cellular physiology.

The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.

G. Taraboletti, R. Giavazzi, M. Rusnati, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin‐like bFGF receptors

M. Rusnati, M. Presta, M Rusnati, 1993, Journal of cellular physiology.

Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives.

D. Ribatti, M. Rusnati, M. Presta, 2001, The Journal of biological chemistry.

Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat*

H Lortat-Jacob, M. Giacca, D. Ribatti, 2001, The Journal of Biological Chemistry.